Targeted therapies, guided by molecular testing, offer significant benefits, including fewer side effects and personalization ...
A collaborative research team, led by scientists at VCU Massey Comprehensive Cancer Center and Huntsman Cancer Institute at ...
This discussion provides a clear overview of current treatment standards and ongoing challenges in the management of advanced ...
Chemotherapy has long been a cornerstone of cancer treatment, saving millions of lives. Stream Connecticut News for free, 24/7, wherever you are. Drugmakers have poured billions of dollars into ...
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced positive top-line results from the Phase 3 HERIZON-GEA-01 trial evaluating ZIIHERA® ...
VANCOUVER, BC, BC / ACCESS Newswire / October 2, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT), a development-stage biopharmaceutical company specializing ...
Ziihera® plus chemotherapy showed a clinically meaningful and statistically significant improvement in PFS versus trastuzumab ...
Dr Sanyo D'Souza Due to rapid developments in molecular biology, cancer treatment has become far more advanced than conventional chemotherapy. Targeted therapy is a type of cancer treatment that is ...
Groundbreaking studies reveal the potential of cell therapies to achieve long-term remission in HPV-associated cancers, ...
Chemotherapy has long been a cornerstone of cancer treatment, saving millions of lives. Drugmakers have poured billions of dollars into developing ADCs. The medicines are designed to deliver potent ...
Chemotherapy has long been a cornerstone of cancer treatment, saving millions of lives. But the pharmaceutical industry says a popular class of targeted cancer therapies could one day replace ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback